Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luvometinib Monotherapy or Combined With Cytarabine for Langerhans Cell Histiocytosis
NCT07728201Phase 2Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Jun 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
A Phase 2 trial of luvometinib in Langerhans cell histiocytosis (LCH), sponsored by Shanghai Ninth People's Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
luvometinib
03
Conditions
Langerhans cell histiocytosis (LCH)
Beyond the preview
Go deeper on NCT07728201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07728201.